Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns TRNO Q1 2026 Earnings Massive EPS Beat as Earnings Surge 99 Above Estimates NBTB Q1 2026 Earnings EPS Misses Estimates Shares Hold Steady EXAS Q4 2025 Earnings Significant EPS Miss Raises Questions on Path to Profitability ENVA Q1 2026 Earnings EPS Beats Estimates by 335 as Shares Dip Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity